** = Publikationen gelistet in SCI/SSCI/Pubmed
** Lackner, EM; Matthaei, M; Meng, H; Ardjomand, N; Eberhart, CG; Jun, AS
Design and analysis of keratoconus tissue microarrays.
Cornea. 2014; 33(1):49-55
Doi: 10.1097/ICO.0000000000000012
Web of Science
PubMed
FullText
FullText_MUG
** Matthaei, M; Hu, J; Kallay, L; Eberhart, CG; Cursiefen, C; Qian, J; Lackner, EM; Jun, AS
Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy.
Invest Ophthalmol Vis Sci. 2014; 55(1):216-225
Doi: 10.1167/iovs.13-12689
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Matthaei, M; Hu, J; Meng, H; Lackner, EM; Eberhart, CG; Qian, J; Hao, H; Jun, AS
Endothelial cell whole genome expression analysis in a mouse model of early-onset Fuchs' endothelial corneal dystrophy.
Invest Ophthalmol Vis Sci. 2013; 54(3):1931-1940
Doi: 10.1167/iovs.12-10898
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Matthaei, M; Lackner, EM; Meng, H; Hicks, JL; Meeker, AK; Eberhart, CG; Jun, AS
Tissue Microarray Analysis of Cyclin-Dependent Kinase Inhibitors p21 and p16 in Fuchs Dystrophy.
Cornea. 2013; 32(4):473-478
Doi: 10.1097/ICO.0b013e31826f324e
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ivastinovic, D; Pöschl, EM; Schwab, C; Borkenstein, A; Lackner, EM; Wedrich, A; Velikay-Parel, M
Evolution of early changes at the vitreoretinal interface after cataract surgery determined by optical coherence tomography and ultrasonography.
Am J Ophthalmol. 2013; 155(2):404-405
Doi: 10.1016/j.ajo.2012.10.007
Web of Science
PubMed
FullText
FullText_MUG
** Wissiak, E; Lackner, EM; Vidic, B; Ardjomand, N;
Phakic intraocular lenses: past and present.
SPEKTRUM AUGENHEILKD. 2013; 27(6): 274-280.
Doi: 10.1007/s00717-013-0190-5
Web of Science
FullText
FullText_MUG
** Ivastinovic, D; Schwab, C; Borkenstein, A; Lackner, EM; Wedrich, A; Velikay-Parel, M
Evolution of early changes at the vitreoretinal interface after cataract surgery determined by optical coherence tomography and ultrasonography.
Am J Ophthalmol. 2012; 153(4): 705-709.
Doi: 10.1016/j.ajo.2011.09.009
Web of Science
PubMed
FullText
FullText_MUG
** Schwab, C; Ivastinovic, D; Borkenstein, A; Lackner, EM; Wedrich, A; Velikay-Parel, M
Prevalence of early and late stages of physiologic PVD in emmetropic elderly population.
Acta Ophthalmol. 2012; 90(3):e179-e184
Doi: 10.1111/j.1755-3768.2011.02310.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prager, GW; Lackner, EM; Krauth, MT; Unseld, M; Poettler, M; Laffer, S; Cerny-Reiterer, S; Lamm, W; Kornek, GV; Binder, BR; Zielinski, CC; Valent, P
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
Mol Oncol. 2010; 4(2): 150-160.
Doi: 10.1016/j.molonc.2010.01.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wackernagel, W; Lackner, EM; Pilz, S; Mayer, C; Stepan, V
von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab.
ACTA OPHTHALMOL. 2010; 88(7): e271-e272.
Doi: 10.1111/j.1755-3768.2009.01611.x
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gleixner, KV; Mayerhofer, M; Vales, A; Gruze, A; Hörmann, G; Cerny-Reiterer, S; Lackner, E; Hadzijusufovic, E; Herrmann, H; Iyer, AK; Krauth, MT; Pickl, WF; Marian, B; Panzer-Grümayer, R; Sillaber, C; Maeda, H; Zielinski, C; Valent, P
Targeting of hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.
Curr Cancer Drug Targets. 2009; 9(5): 675-689.
Doi: 10.2174/156800909789057024
Web of Science
PubMed
FullText
FullText_MUG